Wells Fargo & Company Integra Lifesciences Holdings Corp Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Wells Fargo & Company holds 54,852 shares of IART stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,852

Previous 140,318 60.91%

Holding current value

$1.27 Million

Previous $2.55 Million 51.2%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$16.95 - $26.7 $1.45 Million - $2.28 Million	-85,466 Reduced 60.91%	54,852 $1.24 Million
Q3 2024 Nov 13, 2024	SELL	$17.14 - $31.74 $698,146 - $1.29 Million	-40,732 Reduced 22.5%	140,318 $2.55 Million
Q2 2024 Aug 13, 2024	SELL	$23.14 - $34.72 $5.85 Million - $8.77 Million	-252,677 Reduced 58.26%	181,050 $5.28 Million
Q1 2024 May 10, 2024	SELL	$33.4 - $45.2 $3.91 Million - $5.3 Million	-117,153 Reduced 21.27%	433,727 $15.4 Million
Q4 2023 Feb 09, 2024	BUY	$34.21 - $44.59 $9.04 Million - $11.8 Million	264,128 Added 92.11%	550,880 $24 Million
Q3 2023 Nov 13, 2023	SELL	$37.8 - $45.97 $17.5 Million - $21.3 Million	-462,499 Reduced 61.73%	286,752 $11 Million
Q2 2023 Aug 15, 2023	SELL	$37.95 - $58.98 $12.6 Million - $19.5 Million	-331,208 Reduced 30.65%	749,251 $30.8 Million
Q1 2023 May 12, 2023	BUY	$52.61 - $60.49 $5.71 Million - $6.57 Million	108,583 Added 11.17%	1,080,459 $62 Million
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $10.1 Million - $14 Million	239,745 Added 32.75%	971,876 $54.5 Million
Q3 2022 Nov 14, 2022	SELL	$42.28 - $57.17 $8.93 Million - $12.1 Million	-211,326 Reduced 22.4%	732,131 $31 Million
Q2 2022 Aug 12, 2022	SELL	$53.86 - $66.52 $9.08 Million - $11.2 Million	-168,626 Reduced 15.16%	943,457 $51 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $1.59 Million - $1.75 Million	25,301 Added 2.33%	1,112,083 $71.5 Million
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $3.27 Million - $3.84 Million	-52,406 Reduced 4.6%	1,086,782 $72.8 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $8.08 Million - $9.47 Million	124,291 Added 12.25%	1,139,188 $78 Million
Q2 2021 Aug 16, 2021	BUY	$66.79 - $76.63 $6.74 Million - $7.73 Million	100,882 Added 11.04%	1,014,897 $69.3 Million
Q1 2021 May 13, 2021	BUY	$62.63 - $71.15 $3.99 Million - $4.54 Million	63,782 Added 7.5%	914,015 $63.1 Million
Q4 2020 Feb 09, 2021	BUY	$43.31 - $66.55 $3.79 Million - $5.82 Million	87,492 Added 11.47%	850,233 $55.2 Million
Q3 2020 Nov 05, 2020	SELL	$43.33 - $51.72 $2.13 Million - $2.54 Million	-49,107 Reduced 6.05%	762,741 $36 Million
Q2 2020 Aug 13, 2020	SELL	$41.42 - $55.57 $2.1 Million - $2.82 Million	-50,783 Reduced 5.89%	811,848 $38.1 Million
Q1 2020 May 14, 2020	BUY	$36.67 - $61.04 $31.6 Million - $52.7 Million	862,631 New	862,631 $38.5 Million

Others Institutions Holding IART

# of Institutions

240

Shares Held

73.4M

Call Options Held

592K

Put Options Held

15.2K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.94B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Integra Lifesciences Holdings Corp Transaction History